| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 550 | 2024 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 547 | 2023 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 544 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 509 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 328 | 2024 |
| Incidence of stress cardiomyopathy during the coronavirus disease 2019 pandemic A Jabri, A Kalra, A Kumar, A Alameh, S Adroja, H Bashir, AS Nowacki, ... JAMA network open 3 (7), e2014780-e2014780, 2020 | 281 | 2020 |
| Oral nirmatrelvir and ritonavir in nonhospitalized vaccinated patients with coronavirus disease 2019 S Ganatra, SS Dani, J Ahmad, A Kumar, J Shah, GM Abraham, ... Clinical Infectious Diseases 76 (4), 563-572, 2023 | 154 | 2023 |
| Anti-diabetic effects of the Indian indigenous fruit Emblica officinalis Gaertn: active constituents and modes of action JJ D'souza, PP D'souza, F Fazal, A Kumar, HP Bhat, MS Baliga Food & function 5 (4), 635-644, 2014 | 141 | 2014 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 111 | 2024 |
| Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials A Al-Abdouh, A Bizanti, M Barbarawi, A Jabri, A Kumar, OE Fashanu, ... Contemporary clinical trials 101, 106272, 2021 | 75 | 2021 |
| Impact of social vulnerability on comorbid cancer and cardiovascular disease mortality in the United States S Ganatra, SS Dani, A Kumar, SU Khan, R Wadhera, TG Neilan, ... Cardio Oncology 4 (3), 326-337, 2022 | 68 | 2022 |
| A systematic review of the cardiovascular manifestations and outcomes in the setting of coronavirus-19 disease S Thakkar, S Arora, A Kumar, R Jaswaney, M Faisaluddin, ... Clinical Medicine Insights: Cardiology 14, 1179546820977196, 2020 | 67 | 2020 |
| The burgeoning cardiovascular disease epidemic in Indians–perspectives on contextual factors and potential solutions A Kalra, AP Jose, P Prabhakaran, A Kumar, A Agrawal, A Roy, ... The Lancet Regional Health-Southeast Asia 12, 2023 | 59 | 2023 |
| Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region M Majmundar, T Kansara, JM Lenik, H Park, K Ghosh, R Doshi, P Shah, ... PloS one 15 (9), e0238827, 2020 | 55 | 2020 |
| COVID-19 pandemic: A sentiment analysis: A short review of the emotional effects produced by social media posts during this global crisis A Kumar, SU Khan, A Kalra European Heart Journal 41 (39), 3782-3783, 2020 | 52 | 2020 |
| Impact of SGLT2 inhibitors on AF recurrence after catheter ablation in patients with type 2 diabetes MR Abu-Qaoud, A Kumar, T Tarun, S Abraham, J Ahmad, S Khadke, ... Clinical Electrophysiology 9 (10), 2109-2118, 2023 | 46 | 2023 |
| Meta-analysis of effect of vegetarian diet on ischemic heart disease and all-cause mortality A Jabri, A Kumar, E Verghese, A Alameh, A Kumar, MS Khan, SU Khan, ... American Journal of Preventive Cardiology 7, 100182, 2021 | 46 | 2021 |
| Gender and disparity in first authorship in cardiology randomized clinical trials R Mehran, A Kumar, A Bansal, M Shariff, M Gulati, A Kalra JAMA Network Open 4 (3), e211043-e211043, 2021 | 39 | 2021 |
| Meta-analysis comparing outcomes in patients with and without cardiac injury and coronavirus disease 2019 (COVID 19) A Bansal, A Kumar, D Patel, R Puri, A Kalra, SR Kapadia, GW Reed The American Journal of Cardiology 141, 140-146, 2021 | 34 | 2021 |
| Absolute lymphocyte count as a predictor of mortality and readmission in heart failure hospitalization M Majmundar, T Kansara, H Park, G Ibarra, JM Lenik, P Shah, A Kumar, ... IJC Heart & Vasculature 39, 100981, 2022 | 33 | 2022 |
Ankur Kalra, MD, MScIndiana University School of Medicine, West Lafayette, IndianaVerified email at iu.edu
